Clinical Trial Update: A Study of Acute Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Stem-Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial in acute graft-versus-host disease after allogeneic stem-cell transplantation was terminated; results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: CytoDyn, Inc. | Conditions: Graft Vs Host Disease | Phase 2 | Status: TERMINATED | Results posted: 2024-03-12